CTLA4 and neoplasm: Activation of vasculature in tumors, extravasation and proliferation of T cells, and increased ratios of Teff/Treg and IFN-γ/IL-10 were discovered to be the mechanisms of anti-tumor effects of CTLA-4 blockade in mouse models.